Flatiron Health $1.6B
Flatiron Health acquired by Roche
Flatiron Health, the leading cancer research platform and oncology software, has been acquired by Swiss pharmaceutical giant, Roche for $1.9B, marking the largest NYC tech acquisition in history. According to a press release, Flatiron will continue its current business model with the entire team joining Roche. “Roche has been a tremendous partner to us over the past two years and shares our vision for building a learning healthcare platform in oncology ultimately designed to improve the lives of cancer patients. This important milestone will allow us to increase our investments in our provider-facing technology and services platform, as well as our evidence-generation platform, which will remain available to the entire healthcare industry,” said Nat Turner, Flatiron Health Cofounder and CEO.
Investors in the acquired company: SV Angel, First Round Capital,reessen Horowitz, GV, Great Oaks Venture Capital, BoxGroup, Social Capital, Allen & Company, IA Ventures, David Tisch, Grape Arbor VC, Stripes Group, Baillie Gifford, Aaron Levie, Casdin Capital, LabCorp, Jack Abraham, Jared Hecht, Roche, Edward Zimmerman
Total funding raised: $313M
Full coverage: Flatiron Health Acquired by Roche for $1.9B
The AlleyWatch audience is driving progress and innovation at a global scale. Reaching more individuals in a single month than every other tech-focused organization in NYC combined, AlleyWatch is the highway for technology and entrepreneurship in New York. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including sponsoring a piece like this, which will be read by the vast majority of key influencers in the entrepreneurial universe. Find out more here.